These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 36099786)
1. Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic. Wanchaitanawong W; Thinrungroj N; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K Int Immunopharmacol; 2022 Nov; 112():109230. PubMed ID: 36099786 [TBL] [Abstract][Full Text] [Related]
2. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease. Bhat MA; Usman I; Dhaneshwar S Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409 [TBL] [Abstract][Full Text] [Related]
3. Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study. Allin KH; Jensen CB; Jacobsen RK; Jess T J Gastroenterol; 2022 Oct; 57(10):761-769. PubMed ID: 35780256 [TBL] [Abstract][Full Text] [Related]
4. Hou M; Leng Y; Shi Y; Tan Z; Min X Am J Chin Med; 2023; 51(6):1501-1526. PubMed ID: 37530507 [TBL] [Abstract][Full Text] [Related]
5. Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation. Kostoff RN; Briggs MB; Shores DR World J Gastroenterol; 2020 Sep; 26(33):4889-4899. PubMed ID: 32952337 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382 [TBL] [Abstract][Full Text] [Related]
7. Maximizing Treatment Options for IBD through Drug Repurposing. Barjasteh AH; Al-Asady AM; Latifi H; Al Okla S; Al-Nazwani N; Avan A; Khazaei M; Ryzhikov M; Nadi-Yazdi H; Hassanian SM Curr Pharm Des; 2024; 30(32):2538-2549. PubMed ID: 39039672 [TBL] [Abstract][Full Text] [Related]
8. Review of Saccharomyces boulardii as a treatment option in IBD. Sivananthan K; Petersen AM Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163 [TBL] [Abstract][Full Text] [Related]
9. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases. Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293 [TBL] [Abstract][Full Text] [Related]
10. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Biancheri P; Brezski RJ; Di Sabatino A; Greenplate AR; Soring KL; Corazza GR; Kok KB; Rovedatti L; Vossenkämper A; Ahmad N; Snoek SA; Vermeire S; Rutgeerts P; Jordan RE; MacDonald TT Gastroenterology; 2015 Nov; 149(6):1564-1574.e3. PubMed ID: 26170138 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease Drugs: A Focus on Autophagy. Hooper KM; Barlow PG; Stevens C; Henderson P J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462 [TBL] [Abstract][Full Text] [Related]
12. The Potential of Natural Oils to Improve Inflammatory Bowel Disease. Zhou Y; Wang D; Duan H; Zhou S; Guo J; Yan W Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299569 [TBL] [Abstract][Full Text] [Related]
13. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
14. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Dharmani P; Chadee K Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434 [TBL] [Abstract][Full Text] [Related]
15. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments. Zhou Y; Wang D; Yan W Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839389 [TBL] [Abstract][Full Text] [Related]
16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
17. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia. AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Pearce CB; Duncan HD; Timmis L; Green JR Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998 [TBL] [Abstract][Full Text] [Related]
20. [Polyphenols in the treatment of inflammatory bowel diseases]. Chojnacka K; Laskowska J Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]